Bone Biologics Corp - Warrants (13/10/2026)
BBLGW - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$28.78M
Close$
$2.19
71.5% downside
Current Fair Value
71.5% downsideOvervalued by 71.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $28.78 Million |
|---|---|
| Enterprise Value | $24.75 Million |
| Earnings per Share | $-2.65 |
| Beta | 0.53 |
| Outstanding Shares | 3,737,327 |
Return
| Return on Equity | -72.41% |
|---|---|
| Return on Assets | -64.06% |
| Return on Invested Capital | -75.33% |
Valuation & Multiples
| P/E Ratio | -0.23 |
|---|---|
| PEG | 3.11 |
| Price to Sales | - |
| Price to Book Ratio | 7.7 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.87 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-0.39
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-0.19
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Bone Biologics Corp
2 employees
